Eagle Pharmaceuticals (NASDAQ: EGRX)
Eagle Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Eagle Pharmaceuticals Company Info
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
News & Analysis
3 Stocks the Smartest Investors Are Buying Right Now
Great stocks for smart investors can be found in different corners of the market.
3 Top Biotech Stocks to Buy in 2017
Acadia Pharmaceuticals, Regeneron Pharmaceuticals, and Eagle Pharmaceuticals all look like solid choices for the year ahead.
Why Eagle Pharmaceuticals, Inc. Is Soaring 21.6% Today
A newly minted J-code from CMS provides additional clarity into the company's future sales from Bendeka.
Why Eagle Pharmaceuticals Inc. Flew 38.5% Higher in August
A solid second-quarter earnings report buoyed by good news from the FDA sent shares soaring.
Why Eagle Pharmaceuticals, Inc. Skyrocketed 27.8% Today
A positive decision on a key patent has investors bullish about the company's future.
Here's Why Eagle Pharmaceuticals' Stock Cratered Today
The FDA declines to approve Kangio, sending Eagle's shares spiraling downward today.
The Best Biotech Stocks in 2015
These big biotech winners more than tripled in value this year.
3 Moneymaking Biotech Stocks to Consider Buying
One Foolish contributor shares three intriguing and profitable biotech companies that have caught his eye.
Valuation
Earnings Transcripts
Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call Transcript
EGRX earnings call for the period ending June 30, 2022.
Eagle Pharmaceuticals (EGRX) Q1 2022 Earnings Call Transcript
EGRX earnings call for the period ending March 31, 2022.
Eagle Pharmaceuticals (EGRX) Q4 2021 Earnings Call Transcript
EGRX earnings call for the period ending December 31, 2021.
Eagle Pharmaceuticals, inc (EGRX) Q3 2021 Earnings Call Transcript
EGRX earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.